GlassScriptPhysician profile
Ariel Moradzadeh
NPI 1689107922
$8,744.32
in general payments reported to CMS, 2019-2025
34 companies · $970 in 2025
The $970 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $653 · 2021: $1,315 · 2022: $1,120 · 2023: $1,099 · 2024: $2,281 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,634 · Honoraria: $689 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,633.78 |
| Honoraria | $689.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,060.19 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Ams Ambicor |
| Abbvie INC. | $820.59 | 2020-2025 | |
| Medtronic, INC. | $741.45 | 2022-2025 | Interstim |
| Coloplast Corp | $591.04 | 2021-2024 | Titan |
| Endo Pharmaceuticals INC. | $537.52 | 2020-2023 | Xiaflex |
| Cook Incorporated | $500.00 | 2024 | |
| Endo USA, INC. | $385.69 | 2024-2025 | Xiaflex |
| Heartflow, INC. | $349.71 | 2025 | |
| Genzyme Corporation | $325.00 | 2020 | |
| Urogen Pharma, INC. | $202.79 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $201.00 | 2024 | |
| Axonics, INC. | $153.78 | 2024 | Axonics |
| Mimedx Group, INC. | $150.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.24 | 2024 | Jardiance |
| Antares Pharma, INC. | $95.45 | 2021-2023 | Nocdurna, Xyosted, Tlando |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $71.35 | 2021-2022 | |
| Neurelis, INC. | $39.55 | 2021 | |
| 180 Medical, INC. | $33.65 | 2023 | |
| Inspire Medical Systems, INC. | $33.51 | 2024 | Inspire |
| Lilly USA, LLC | $30.02 | 2024-2025 | Kisunla |
| Teva Pharmaceuticals USA, INC. | $29.40 | 2023 | Austedo Xr |
| Amneal Pharmaceuticals LLC | $25.45 | 2025 | Crexont |
| Sumitomo Pharma America, INC. | $23.72 | 2025 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $23.66 | 2022 | |
| Lundbeck LLC | $23.50 | 2024 | Vyepti |
| Teleflex LLC | $23.34 | 2023 | Urolift |
| Abbott Laboratories | $21.15 | 2023 | Perclose Proglide |
| Bayer Healthcare Pharmaceuticals INC. | $19.32 | 2023 | |
| Impel Pharmaceuticals INC. | $18.70 | 2022 | |
| Hologic Sales and Service, LLC | $17.66 | 2023 | Localizer |
| Abc Home Medical Supply, INC. | $15.89 | 2025 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
| Biohaven Pharmaceutical Holding Company LTD. | $14.67 | 2022 | |
| Clarus Therapeutics INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Moradzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.